Nombre del producto:Ethyl 2-(3-cyclopropyl-6-oxopyridazin-1(6H)-yl)acetate

IUPAC Name:ethyl 2-(3-cyclopropyl-6-oxo-1,6-dihydropyridazin-1-yl)acetate

CAS:2098136-65-1
Fórmula molecular:C11H14N2O3
Pureza:97%
Número de catálogo:CM557913
Peso molecular:222.24

Unidad de embalaje Stock disponible Precio($) Cantidad
CM557913-100mg in stock ƻƻƅ
CM557913-250mg in stock ŭƻƅ
CM557913-1g in stock ȋƩȋ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2098136-65-1
Fórmula molecular:C11H14N2O3
Punto de fusión:-
Código de sonrisas:O=C(C=C1)N(CC(OCC)=O)N=C1C2CC2
Densidad:
Número de catálogo:CM557913
Peso molecular:222.24
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Pyridazines
Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.
Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.

Related Products